Aura Biosciences AURA Stock
Aura Biosciences Price Chart
Aura Biosciences AURA Financial and Trading Overview
| Aura Biosciences stock price | 6.16 USD |
| Previous Close | 12.44 USD |
| Open | 12.28 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 900 |
| Day's Range | 12.28 - 12.63 USD |
| 52 Week Range | 8.13 - 24.83 USD |
| Volume | 55.16K USD |
| Avg. Volume | 97.89K USD |
| Market Cap | 476.66M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.67 USD |
AURA Valuation Measures
| Enterprise Value | 317.35M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.3206754 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.64416 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.832 |
Trading Information
Aura Biosciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -8.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24.83 USD |
| 52 Week Low | 8.13 USD |
| 50-Day Moving Average | 10.42 USD |
| 200-Day Moving Average | 11.67 USD |
AURA Share Statistics
| Avg. Volume (3 month) | 97.89K USD |
| Avg. Daily Volume (10-Days) | 61.45K USD |
| Shares Outstanding | 37.8M |
| Float | 18.46M |
| Short Ratio | 33.29 |
| % Held by Insiders | 8.26% |
| % Held by Institutions | 73.86% |
| Shares Short | 2.2M |
| Short % of Float | 7.33% |
| Short % of Shares Outstanding | 5.83% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.73% |
| Return on Equity (ttm) | -39.45% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -65679000 USD |
| Net Income Avi to Common (ttm) | -63394000 USD |
| Diluted EPS (ttm) | -1.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 173.52M USD |
| Total Cash Per Share (mrq) | 4.59 USD |
| Total Debt (mrq) | 20.64M USD |
| Total Debt/Equity (mrq) | 11.45 USD |
| Current Ratio (mrq) | 22.095 |
| Book Value Per Share (mrq) | 4.769 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -55813000 USD |
| Levered Free Cash Flow (ttm) | -33009000 USD |
Profile of Aura Biosciences
| Country | United States |
| State | MA |
| City | Boston |
| Address | 80 Guest Street |
| ZIP | 02135 |
| Phone | 617 500 8864 |
| Website | https://www.aurabiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 70 |
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011, a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications, including choroidal metastases and is in Phase 2 dose-escalation trial. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Q&A For Aura Biosciences Stock
What is a current AURA stock price?
Aura Biosciences AURA stock price today per share is 6.16 USD.
How to purchase Aura Biosciences stock?
You can buy AURA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aura Biosciences?
The stock symbol or ticker of Aura Biosciences is AURA.
Which industry does the Aura Biosciences company belong to?
The Aura Biosciences industry is Biotechnology.
How many shares does Aura Biosciences have in circulation?
The max supply of Aura Biosciences shares is 62M.
What is Aura Biosciences Price to Earnings Ratio (PE Ratio)?
Aura Biosciences PE Ratio is now.
What was Aura Biosciences earnings per share over the trailing 12 months (TTM)?
Aura Biosciences EPS is -1.9 USD over the trailing 12 months.
Which sector does the Aura Biosciences company belong to?
The Aura Biosciences sector is Healthcare.
Aura Biosciences AURA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19167.81 USD — |
+0.35
|
4.02B USD — | 19162.96 USD — | 19389.39 USD — | — - | 4.02B USD — |
| NASDAQ Global Market Composite NQGM | 1960.37 USD — |
+0.32
|
— — | 1960.35 USD — | 1978.1 USD — | — - | — — |
| Nasdaq Health Care IXHC | 950.01 USD — |
+0.92
|
— — | 942.74 USD — | 952.23 USD — | — - | — — |
- {{ link.label }} {{link}}